David D. Anderson

975 total citations
26 papers, 771 citations indexed

About

David D. Anderson is a scholar working on Molecular Biology, Infectious Diseases and Virology. According to data from OpenAlex, David D. Anderson has authored 26 papers receiving a total of 771 indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Molecular Biology, 8 papers in Infectious Diseases and 6 papers in Virology. Recurrent topics in David D. Anderson's work include HIV/AIDS drug development and treatment (7 papers), HIV Research and Treatment (6 papers) and HIV/AIDS Research and Interventions (4 papers). David D. Anderson is often cited by papers focused on HIV/AIDS drug development and treatment (7 papers), HIV Research and Treatment (6 papers) and HIV/AIDS Research and Interventions (4 papers). David D. Anderson collaborates with scholars based in United States, Japan and United Kingdom. David D. Anderson's co-authors include Arun K. Ghosh, Hiroaki Mitsuya, Irene T. Weber, Chun Wel Lin, Michael J. Coghlan, Steven W. Elmore, John K. Pratt, Yasuhiro Koh, Curtis M. Tyree and Michael A. Stashko and has published in prestigious journals such as Journal of Biological Chemistry, Angewandte Chemie International Edition and Analytical Biochemistry.

In The Last Decade

David D. Anderson

23 papers receiving 749 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
David D. Anderson United States 16 320 266 183 149 86 26 771
Sonia de Castro Spain 21 476 1.5× 410 1.5× 134 0.7× 60 0.4× 23 0.3× 58 1.1k
Michael Hale United States 13 240 0.8× 329 1.2× 148 0.8× 75 0.5× 67 0.8× 18 650
Jay A. Markwalder United States 13 285 0.9× 467 1.8× 146 0.8× 69 0.5× 42 0.5× 18 897
Olaf Kinzel Italy 17 255 0.8× 389 1.5× 122 0.7× 72 0.5× 39 0.5× 42 964
Kendra E. Hightower United States 13 132 0.4× 472 1.8× 240 1.3× 197 1.3× 31 0.4× 20 745
Pétra Blom Netherlands 12 135 0.4× 99 0.4× 41 0.2× 41 0.3× 65 0.8× 22 361
István Káldor United States 11 219 0.7× 123 0.5× 111 0.6× 72 0.5× 58 0.7× 21 482
Paul L. Domanico United States 14 78 0.2× 257 1.0× 113 0.6× 64 0.4× 30 0.3× 22 522
Timothy J. Allison United States 13 69 0.2× 343 1.3× 90 0.5× 129 0.9× 77 0.9× 13 760
Ajay D. Pillai United States 15 303 0.9× 202 0.8× 43 0.2× 41 0.3× 62 0.7× 21 938

Countries citing papers authored by David D. Anderson

Since Specialization
Citations

This map shows the geographic impact of David D. Anderson's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by David D. Anderson with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites David D. Anderson more than expected).

Fields of papers citing papers by David D. Anderson

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by David D. Anderson. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by David D. Anderson. The network helps show where David D. Anderson may publish in the future.

Co-authorship network of co-authors of David D. Anderson

This figure shows the co-authorship network connecting the top 25 collaborators of David D. Anderson. A scholar is included among the top collaborators of David D. Anderson based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with David D. Anderson. David D. Anderson is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
Anderson, David D., et al.. (2020). A Regulatory Perspective on Manufacturing Processes Pertaining to Lyophilized Injectable Products. The AAPS Journal. 22(5). 100–100. 8 indexed citations
3.
Effenberger, Kerstin A., David D. Anderson, Walter M. Bray, et al.. (2013). Coherence between Cellular Responses and in Vitro Splicing Inhibition for the Anti-tumor Drug Pladienolide B and Its Analogs. Journal of Biological Chemistry. 289(4). 1938–1947. 61 indexed citations
4.
Ghosh, Arun K., David D. Anderson, Irene T. Weber, & Hiroaki Mitsuya. (2012). Enhancing Protein Backbone Binding—A Fruitful Concept for Combating Drug‐Resistant HIV. Angewandte Chemie International Edition. 51(8). 1778–1802. 120 indexed citations
5.
Ghosh, Arun K. & David D. Anderson. (2012). Enantioselective Total Synthesis of Pladienolide B: A Potent Spliceosome Inhibitor. Organic Letters. 14(18). 4730–4733. 48 indexed citations
6.
Ghosh, Arun K., David D. Anderson, Irene T. Weber, & Hiroaki Mitsuya. (2012). ChemInform Abstract: Enhancing Protein Backbone Binding — A Fruitful Concept for Combating Drug‐Resistant HIV.. ChemInform. 43(24). 1 indexed citations
7.
Ghosh, Arun K. & David D. Anderson. (2011). Tetrahydrofuran, Tetrahydropyran, Triazoles and Related Heterocyclic Derivatives as HIV Protease Inhibitors. Future Medicinal Chemistry. 3(9). 1181–1197. 45 indexed citations
8.
9.
Ghosh, Arun K., et al.. (2008). L-Selectride-Mediated Highly Diastereoselective Asymmetric Reductive Aldol Reaction: Access to an Important Subunit for Bioactive Molecules. Organic Letters. 10(21). 4811–4814. 25 indexed citations
10.
Varie, David L., Christopher M. Beck, David Hay, et al.. (2007). Design, Development, and Scale-Up of a Selective meso-Epoxide Desymmetrization Process. Organic Process Research & Development. 11(3). 546–559. 16 indexed citations
11.
Longenecker, Kenton L., Elizabeth H. Fry, Clarissa G. Jakob, et al.. (2005). Structure‐based Optimization of MurF Inhibitors. Chemical Biology & Drug Design. 67(1). 58–65. 30 indexed citations
12.
Elmore, Steven W., John K. Pratt, Michael J. Coghlan, et al.. (2004). Differentiation of in vitro transcriptional repression and activation profiles of selective glucocorticoid modulators. Bioorganic & Medicinal Chemistry Letters. 14(7). 1721–1727. 41 indexed citations
13.
Gu, Yu, Alan S. Florjancic, Richard F. Clark, et al.. (2003). Structure–activity relationships of novel potent MurF inhibitors. Bioorganic & Medicinal Chemistry Letters. 14(1). 267–270. 42 indexed citations
14.
Weaver, Connie M., Dorothy Teegarden, Roseann M. Lyle, et al.. (2001). Impact of exercise on bone health and contraindication of oral contraceptive use in young women. Medicine & Science in Sports & Exercise. 33(6). 873–880. 52 indexed citations
15.
Elmore, Steven W., Michael J. Coghlan, David D. Anderson, et al.. (2001). Nonsteroidal Selective Glucocorticoid Modulators:  the Effect of C-5 Alkyl Substitution on the Transcriptional Activation/Repression Profile of 2,5-Dihydro-10-methoxy-2,2,4-trimethyl-1H-[1]benzopyrano[3,4-f]quinolines. Journal of Medicinal Chemistry. 44(25). 4481–4491. 94 indexed citations
16.
Anderson, David D., B. M. Hillberry, Dorothy Teegarden, et al.. (1996). Biomechanical Analysis of an Exercise Program for Forces and Stresses in the Hip Joint and Femoral Neck. Journal of Applied Biomechanics. 12(3). 292–312. 13 indexed citations
17.
McNitt-Gray, Jill L., et al.. (1991). Adjustments in kinematics and kinetics during modified landings. Journal of Biomechanics. 24(3-4). 244–244. 2 indexed citations
18.
Cherny, Robert W. & David D. Anderson. (1982). William Jennings Bryan. Journal of American History. 69(1). 191–191. 2 indexed citations
19.
Anderson, David D., et al.. (1979). [30] In Situ immunoassays for translation products. Methods in enzymology on CD-ROM/Methods in enzymology. 68. 428–436. 8 indexed citations
20.
Anderson, David D., et al.. (1976). A quantitative method for the measurement of cellular guanosine triphosphate pool specific activities. Analytical Biochemistry. 71(1). 37–41. 16 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Sonia de Castro Breakdown of academic impact, for papers by Michael Hale Breakdown of academic impact, for papers by Jay A. Markwalder Breakdown of academic impact, for papers by Olaf Kinzel Breakdown of academic impact, for papers by Kendra E. Hightower Breakdown of academic impact, for papers by Pétra Blom Breakdown of academic impact, for papers by István Káldor Breakdown of academic impact, for papers by Paul L. Domanico Breakdown of academic impact, for papers by Timothy J. Allison Breakdown of academic impact, for papers by Ajay D. Pillai
Rankless by CCL
2026